Detalhe da pesquisa
1.
Orthogonal SARS-CoV-2 Serological Assays Enable Surveillance of Low-Prevalence Communities and Reveal Durable Humoral Immunity.
Immunity
; 53(5): 925-933.e4, 2020 11 17.
Artigo
em Inglês
| MEDLINE | ID: mdl-33129373
2.
Ibritumomab consolidation after 3 cycles of CHOP plus radiotherapy in high-risk limited-stage aggressive B-cell lymphoma: SWOG S0313.
Blood
; 125(2): 236-41, 2015 Jan 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-25395425
3.
Phase 2 study of imexon, a prooxidant molecule, in relapsed and refractory B-cell non-Hodgkin lymphoma.
Blood
; 124(8): 1259-65, 2014 Aug 21.
Artigo
em Inglês
| MEDLINE | ID: mdl-25016003
4.
Genetic polymorphisms in oxidative stress-related genes are associated with outcomes following treatment for aggressive B-cell non-Hodgkin lymphoma.
Am J Hematol
; 89(6): 639-45, 2014 Jun.
Artigo
em Inglês
| MEDLINE | ID: mdl-24633940
5.
Optimizing assessment of CD30 expression in Hodgkin lymphoma by controlling for low expression.
Histol Histopathol
; 39(3): 319-331, 2024 Mar.
Artigo
em Inglês
| MEDLINE | ID: mdl-37377225
6.
Phase 2 trial of combined cisplatin, etoposide, gemcitabine, and methylprednisolone (PEGS) in peripheral T-cell non-Hodgkin lymphoma: Southwest Oncology Group Study S0350.
Cancer
; 119(2): 371-9, 2013 Jan 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-22833464
7.
Impact of histological grading on survival in the SWOG S0016 follicular lymphoma cohort.
Haematologica
; 103(4): e151-e153, 2018 04.
Artigo
em Inglês
| MEDLINE | ID: mdl-29472351
8.
Peripheral T-Cell Lymphoma in a Patient Previously Diagnosed With Sarcoidosis.
J Hematol
; 12(6): 272-276, 2023 Dec.
Artigo
em Inglês
| MEDLINE | ID: mdl-38188478
9.
Subclonal TP53 mutations are frequent and predict resistance to radioimmunotherapy in follicular lymphoma.
Blood Adv
; 7(17): 5082-5090, 2023 09 12.
Artigo
em Inglês
| MEDLINE | ID: mdl-37379264
10.
SARS-CoV-2 Rapid Antigen Testing of Symptomatic and Asymptomatic Individuals on the University of Arizona Campus.
Biomedicines
; 9(5)2021 May 12.
Artigo
em Inglês
| MEDLINE | ID: mdl-34066047
11.
Detection, prevalence, and duration of humoral responses to SARS-CoV-2 under conditions of limited population exposure.
medRxiv
; 2020 Aug 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-32817969
12.
Continued Excellent Outcomes in Previously Untreated Patients With Follicular Lymphoma After Treatment With CHOP Plus Rituximab or CHOP Plus 131I-Tositumomab: Long-Term Follow-Up of Phase III Randomized Study SWOG-S0016.
J Clin Oncol
; 36(7): 697-703, 2018 03 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-29356608
13.
Phase I Study of the Investigational Aurora A Kinase Inhibitor Alisertib plus Rituximab or Rituximab/Vincristine in Relapsed/Refractory Aggressive B-cell Lymphoma.
Clin Cancer Res
; 24(24): 6150-6159, 2018 12 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-30082475
14.
Co-targeting aurora kinase with PD-L1 and PI3K abrogates immune checkpoint mediated proliferation in peripheral T-cell lymphoma: a novel therapeutic strategy.
Oncotarget
; 8(59): 100326-100338, 2017 Nov 21.
Artigo
em Inglês
| MEDLINE | ID: mdl-29245981
15.
Disruption of Aneuploidy and Senescence Induced by Aurora Inhibition Promotes Intrinsic Apoptosis in Double Hit or Double Expressor Diffuse Large B-cell Lymphomas.
Mol Cancer Ther
; 16(10): 2083-2093, 2017 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-28615297
16.
Diffuse aggressive histologies of non-hodgkin lymphoma: treatment and biology of limited disease.
Semin Hematol
; 43(4): 207-12, 2006 Oct.
Artigo
em Inglês
| MEDLINE | ID: mdl-17027654
17.
Transcript profiling in peripheral T-cell lymphoma, not otherwise specified, and diffuse large B-cell lymphoma identifies distinct tumor profile signatures.
Mol Cancer Ther
; 4(12): 1867-79, 2005 Dec.
Artigo
em Inglês
| MEDLINE | ID: mdl-16373702
18.
Assessment of carbonic anhydrase IX expression and extracellular pH in B-cell lymphoma cell line models.
Leuk Lymphoma
; 56(5): 1432-9, 2015 May.
Artigo
em Inglês
| MEDLINE | ID: mdl-25130478
19.
Phase II Intergroup Trial of Alisertib in Relapsed and Refractory Peripheral T-Cell Lymphoma and Transformed Mycosis Fungoides: SWOG 1108.
J Clin Oncol
; 33(21): 2399-404, 2015 Jul 20.
Artigo
em Inglês
| MEDLINE | ID: mdl-26077240
20.
Alisertib (MLN8237) an investigational agent suppresses Aurora A and B activity, inhibits proliferation, promotes endo-reduplication and induces apoptosis in T-NHL cell lines supporting its importance in PTCL treatment.
Leuk Res
; 37(4): 434-9, 2013 Apr.
Artigo
em Inglês
| MEDLINE | ID: mdl-23153524